Author

Vadim Tsvetnitsky

Director, Vaccine Development, IAVI - Cited by 667 - vaccine development

Biography

Vadim Tsvetnitsky  is currently working as a Professor in the Department of Vaccinology. His research interests includes vaccine development, vaccines, vaccination, immunology. He is serving as an editorial member and reviewer of several international reputed journals. He has successfully completed his Administrative responsibilities. Vadim Tsvetnitsky has authored of many research articles/books related to Vaccine development.  
Title
Cited by
Year
Universal influenza vaccines: Shifting to better vaccines
FB Scorza, V Tsvetnitsky, JJ DonnellyVaccine 34 (26), 2926-2933, 2016201
163
2016
H3 stalk-based chimeric hemagglutinin influenza virus constructs protect mice from H7N9 challenge
F Krammer, I Margine, R Hai, A Flood, A Hirsh, V Tsvetnitsky, D Chen, ...Journal of virology 88 (4), 2340-2343, 2014201
120
2014
Fatty acyl-CoA binding domain of the transcription factor FadR: characterization by deletion, affinity labeling, and isothermal titration calorimetry
CC DiRusso, V Tsvetnitsky, P Højrup, J KnudsenJournal of Biological Chemistry 273 (50), 33652-33659, 1998199
68
1998
Evaluating Burkholderia pseudomallei Bip proteins as vaccines and Bip antibodies as detection agents
C Druar, F Yu, JL Barnes, RT Okinaka, N Chantratita, S Beg, CW Stratilo, ...FEMS Immunology & Medical Microbiology 52 (1), 78-87, 2008200
65
2008
Assessment of human immune responses to H7 avian influenza virus of pandemic potential: Results from a placebo–controlled, randomized double–blind phase I study of live …
L Rudenko, I Kiseleva, AN Naykhin, M Erofeeva, M Stukova, S Donina, ...PloS one 9 (2), e87962, 2014201
64
2014
Clinical testing of pre-pandemic live attenuated A/H5N2 influenza candidate vaccine in adult volunteers: results from a placebo-controlled, randomized double-blind phase I study
L Rudenko, I Kiseleva, M Stukova, M Erofeeva, A Naykhin, S Donina, ...Vaccine 33 (39), 5110-5117, 2015201
32
2015
Development and pre-clinical evaluation of two LAIV strains against potentially pandemic H2N2 influenza virus
I Isakova-Sivak, J de Jonge, T Smolonogina, A Rekstin, G van Amerongen, ...PloS one 9 (7), e102339, 2014201
30
2014
Preparation and characterization of monopegylated human granulocyte-macrophage colony-stimulating factor
DL Lee, I Sharif, S Kodihalli, DIH Stewart, V TsvetnitskyJournal of Interferon & Cytokine Research 28 (2), 101-112, 2008200
30
2008
Live attenuated influenza vaccines against highly pathogenic H5N1 avian influenza: Development and preclinical characterization
N Larionova, I Kiseleva, I Isakova-Sivak, A Rekstin, I Dubrovina, ...Vaccines Vaccination 4 (8), 208, 2013201
24
2013
Cross-protection against H7N9 influenza strains using a live-attenuated H7N3 virus vaccine
DM Carter, CE Bloom, GA Kirchenbaum, V Tsvetnitsky, I Isakova-Sivak, ...Vaccine 33 (1), 108-116, 151
20
2015
Purification and characterization of recombinant Streptomyces griseus aminopeptidase
SX Ni, D Cossar, A Man, K Norek, D Miller, C Kearse, V TsvetnitskyProtein expression and purification 30 (1), 62-68, 2003200
15
2003
Characterization of phospholipid methylation in rat brain myelin
V Tsvetnitsky, L Auchi, A Nicolaou, WA GibbonsBiochemical Journal 307 (1), 239-244, 1995199
14
1995
S-adenosyl-l-homocysteine and 5′-methylthioadenosine inhibit binding of [3H] flunitrazepam to rat brain membranes
V Tsvetnitsky, IC Campbell, WA GibbonsEuropean journal of pharmacology 282 (1-3), 255-258, 1995199
10
1995
PATH Influenza Vaccine Project: accelerating the development of new influenza vaccines for low-resource countries
KM Neuzil, V Tsvetnitsky, LJ Nyari, RA Bright, JW Boslego, ...Expert review of vaccines 11 (8), 939-947, 2012201
6
2012
Safety and immunogenicity of inactivated monovalent influenza A/H1N1 vaccine candidate manufactured in Vietnam
HV Thang, VM Huong, JC Victor, CB Van, NT Nga, NP Cuong, ...Vaccine 36 (46), 6918-695, 01801
2
2018
The purification and molecular weight determination of rat liver microsomal phospholipid N-methyltransferase
WA Gibbons, L Auchi, K McBride, AN Fonteh, B Larijani, V Tsvetnitsky, ...Biochemical Society Transactions 1 (4), 449S-449S, 1993199
2
1993
Use of transient transfection for cGMP manufacturing of eOD-GT8 60mer, a self-assembling nanoparticle germline-targeting HIV-1 vaccine candidate
Use of transient transfection for cGMP manufacturing of eOD-GT8 60mer, a self-assembling nanoparticle germline-targeting HIV- vaccine candidateVK Sharma, V Tsvetnitsky, S Menis, ET Brower, E Sayeed, J Ackland, ...bioRxiv, 2022.09. 30.5030, 2022202
1
2022
Isozymes of rat brain myelin phospholipid-N-methyltransferase
V TSVETNITSKY, L AUCHI, FA YEBOAH, WA GIBBONSBiochemical Society Transactions 2 (4), 489S-489S, 99399
1
1993

Referred From: https://scholar.google.com/citations?hl=en&user=kSw6N34AAAAJ

Cited by
Citations 667
h-index 12
i10-index 13
Recommended Journals
Open Access Journals